Most Promising Approaches to Improve Stroke Outcomes: The Stroke Treatment Academic Industry Roundtable XII Workshop.


Journal

Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266

Informations de publication

Date de publication:
Dec 2023
Historique:
medline: 29 11 2023
pubmed: 27 10 2023
entrez: 27 10 2023
Statut: ppublish

Résumé

The Stroke Treatment Academic Industry Roundtable XII included a workshop to discuss the most promising approaches to improve outcome from acute stroke. The workshop brought together representatives from academia, industry, and government representatives. The discussion examined approaches in 4 epochs: pre-reperfusion, reperfusion, post-reperfusion, and access to acute stroke interventions. The participants identified areas of priority for developing new and existing treatments and approaches to improve stroke outcomes. Although many advances in acute stroke therapy have been achieved, more work is necessary for reperfusion therapies to benefit the most possible patients. Prioritization of promising approaches should help guide the use of resources and investigator efforts.

Identifiants

pubmed: 37886850
doi: 10.1161/STROKEAHA.123.044279
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

3202-3213

Auteurs

Lawrence R Wechsler (LR)

University of Pittsburgh School of Medicine and University of Pittsburgh Medical Center, PA (L.R.W.).

Opeolu Adeoye (O)

Washington University School of Medicine, St. Louis, MO (O.A.).

Fana Alemseged (F)

University of Melbourne, Australia (F.A.).

Mersedeh Bahr-Hosseini (M)

University of California, Los Angeles School of Medicine, CA (M.B.-H.).

Emir Deljkich (E)

Imperative Care, Campbell, CA (E.D.).

Christopher Favilla (C)

niversity of Pennsylvania School of Medicine, Philadelphia (C.F.).

Marc Fisher (M)

Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (M.F.).

James Grotta (J)

Memorial Hermann Hospital, Houston, TX (J.G.).

Michael D Hill (MD)

University of Calgary, Canada (M.D.H.).

Hooman Kamel (H)

Weill Cornel School of Medicine, New York, NY (H.K.).

Pooja Khatri (P)

University of Cincinnati Medical Center, OH (P.K.).

Patrick Lyden (P)

University of Southern California, Los Angeles, CA (P.L.).

Mahmood Mirza (M)

Cerenovus Irvine, CA (M.M.).

Thanh N Nguyen (TN)

Boston University, MA (T.N.N.).

Edgar Samaniego (E)

University of Iowa, Iowa City (E.S.).

Lee Schwamm (L)

Massachusetts General Hospital, Boston (L.S.).

Magdy Selim (M)

Beth Israel Deaconess Medical Center, Boston, MA (M.S.).

Gisele Silva (G)

Federal University of Sao Paolo, Brazil (G.S.).

Dileep R Yavagal (DR)

University of Miami School of Medicine, FL (D.R.Y.).

Midori A Yenari (MA)

San Francisco Veterans Affairs Medical Center, CA (M.A.Y.).

Kori S Zachrison (KS)

Massachusetts General Hospital, Boston (K.S.Z.).

Johannes Boltze (J)

School of Life Sciences, University of Warwick, Coventry, United Kingdom (J.B.).

Shadi Yaghi (S)

Brown University, Providence, RI (S.Y.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH